These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27095301)

  • 1. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus.
    Rossignol JF
    J Infect Public Health; 2016; 9(3):227-30. PubMed ID: 27095301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Small-Molecule MERS-CoV Inhibitors.
    Liang R; Wang L; Zhang N; Deng X; Su M; Su Y; Hu L; He C; Ying T; Jiang S; Yu F
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30562987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Al-Tawfiq JA; Memish ZA
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):269-275. PubMed ID: 27937060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of peptidic MERS-CoV entry inhibitors].
    Xia S; Wang Q; Liu SW; Lu L; Jiang SB
    Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective inhibition of MERS-CoV infection by resveratrol.
    Lin SC; Ho CT; Chuo WH; Li S; Wang TT; Lin CC
    BMC Infect Dis; 2017 Feb; 17(1):144. PubMed ID: 28193191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational modeling of the bat HKU4 coronavirus 3CL
    Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
    Han HJ; Liu JW; Yu H; Yu XJ
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small molecular agents against MERS-CoV infection].
    Zeng XY; Lu L; Jiang SB; Liu SW
    Yao Xue Xue Bao; 2015 Dec; 50(12):1520-6. PubMed ID: 27169271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.
    Khalid M; Al Rabiah F; Khan B; Al Mobeireek A; Butt TS; Al Mutairy E
    Antivir Ther; 2015; 20(1):87-91. PubMed ID: 24831606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
    Zhou Y; Yang Y; Huang J; Jiang S; Du L
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.
    Agrawal AS; Garron T; Tao X; Peng BH; Wakamiya M; Chan TS; Couch RB; Tseng CT
    J Virol; 2015 Apr; 89(7):3659-70. PubMed ID: 25589660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective.
    Rabaan AA; Alahmed SH; Bazzi AM; Alhani HM
    J Med Microbiol; 2017 Sep; 66(9):1261-1274. PubMed ID: 28855003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
    Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
    Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
    Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
    Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MERS-CoV spike protein: a key target for antivirals.
    Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
    Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Kotani O; Sato H; Sekimukai H; Fukushi S; Suzuki T; Sato Y; Takeda M; Tashiro M; Hasegawa H; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERS-CoV: Understanding the Latest Human Coronavirus Threat.
    Chafekar A; Fielding BC
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29495250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
    Nakagawa K; Narayanan K; Wada M; Makino S
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
    Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
    mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.